Previous studies have indicated that syndecan-1 is a marker for the prognosis and severity of sepsis, acute kidney injury, trauma, and heart failure (14, 16, 24), suggesting that it may serve as a predictive biomarker of mortality in critically ill patients (14, 16, 24). This evidence concerns the gene SDC1 and Sepsis.